K.J. Harris

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Researcher

NCTR

Also affiliated: United States Food and Drug Administration (2022)

Graduate Student Researcher

1 h-index 2 pubs 2 cited

Research Areas

Biomedical Subjects

OverviewAI-generated summary

K.J. Harris, affiliated with the National Center for Toxicological Research, investigates the effects of nanoparticles on biological systems, particularly focusing on drug delivery and intestinal interactions. Their recent work includes assessing the risk of nanocrystal-formulated Zileuton, an oral drug categorized as BCS-II due to its poor solubility. This research specifically examines how Zileuton nanocrystals impact intestinal phase I/II metabolic enzymes and epithelial permeability. A notable aspect of this study is its investigation into sex-dependent alterations in these physiological processes. Harris collaborates with researchers Sangeeta Khare, Kuppan Gokulan, Anshel Bright, and Yaswanthi Yanamadala, all from the National Center for Toxicological Research, on shared publications. With two publications and two citations, Harris's h-index is 1, reflecting early-stage research contributions in the field of toxicology and drug formulation.

Metrics

h-index: 1
Publications: 2
Citations: 2

Selected Publications

Zileuton nanocrystals alter intestinal phase I/II metabolic enzymes and epithelial permeability in a sex-dependent manner (2025)

Drug Metabolism and Disposition 1 citation DOI OpenAlex

View all publications on OpenAlex →